Skip to content

Charlie's Holdings, Inc.

CHUC · OTCM

CIK 1134765fmd_16PY2TS0F3GGF5V9ZCX5EZK9VSManufacturing · Medicinal Chemicals & Botanical ProductsTemplate: Standard

Coverage: Jan 01, 2010 to Jun 30, 2026, 66 periods

Income Statement · Annual · Millions · USD
Line itemFY2017FY2018FY2019FY2020FY2020FY2021FY2022FY2023FY2024FY2025
Total revenues42123–17212616821
Cost of revenue3910–7–––515
Gross profit1113–9–––36
Research and development–01–3010––
Selling, general and administrative11517–131011868
Total operating expenses151429–2321281868
Operating income(14)7(6)–(7)1(2)(2)(3)(2)
Interest expense010–000011
Interest and investment income––––––––––
Other non-operating income (expense)204–(0)500(1)7
Income before taxes––––(7)5(2)(2)(4)5
Income tax expense000–00(0)000
Net income from continuing operations––––(7)5(2)(2)(4)4
Net income(12)7(2)–(7)5(2)(2)(4)4
Net income to common shareholders(13)7(4)(7)–5(2)–(4)4
Charlie's Holdings, Inc. (CHUC) financial statements · FinancialMD